SYAP1 Inhibitors
SYAP1 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of SYAP1 (Synapse-Associated Protein 1), a protein involved in intracellular signaling and potentially linked to synaptic function and cell survival pathways. SYAP1 is known to interact with several key signaling molecules within the cell, contributing to the regulation of various processes such as cell growth, differentiation, and communication between neurons. It is often associated with synaptic structures, where it may play a role in modulating synaptic plasticity, which is essential for learning and memory. By inhibiting SYAP1, these compounds disrupt its ability to facilitate these signaling pathways, which can lead to changes in cellular dynamics and synaptic functioning.
The mechanisms of action of SYAP1 inhibitors can vary depending on how the compound interacts with the protein. Some inhibitors may directly bind to the functional domains of SYAP1, preventing its interaction with other proteins and disrupting the formation of signaling complexes. Others may induce conformational changes that reduce SYAP1's ability to localize at synaptic sites or interfere with its capacity to modulate downstream signaling cascades. Inhibition of SYAP1 affects intracellular pathways involved in cellular communication, particularly those related to synaptic function and plasticity. Research into SYAP1 inhibitors provides insights into the molecular mechanisms governing synaptic regulation and cell signaling, offering a deeper understanding of the role SYAP1 plays in maintaining neural communication and structural integrity within cells. Understanding how these inhibitors work also contributes to broader knowledge of protein interactions that regulate cellular growth and neuronal function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ML-9 | 105637-50-1 | sc-200519 sc-200519A sc-200519B sc-200519C | 10 mg 50 mg 100 mg 250 mg | $112.00 $449.00 $673.00 $1224.00 | 2 | |
ML-9 is a kinase inhibitor that can inhibit myosin light chain kinase (MLCK). SYAP1, being a synapse-associated protein, may interact with cytoskeletal elements regulated by MLCK, leading to its functional inhibition through the control of cytoskeletal dynamics. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts Golgi apparatus function, which could indirectly inhibit SYAP1 by affecting its proper trafficking and membrane localization, crucial for synapse function. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin is an inhibitor of the N-WASP, a regulator of actin polymerization. Since SYAP1 is involved in synaptic organization, inhibiting actin dynamics can reduce the synaptic stability and function where SYAP1 is implicated. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D binds to actin filaments, preventing their elongation. Since SYAP1 is associated with the synapse, disruption of actin dynamics could impair synaptic function, indirectly inhibiting SYAP1 activity. | ||||||
Latrunculin A, Latrunculia magnifica | 76343-93-6 | sc-202691 sc-202691B | 100 µg 500 µg | $265.00 $815.00 | 36 | |
Latrunculin A binds to actin monomers and inhibits their polymerization. Disruption of actin cytoskeleton affects neuronal morphology and may inhibit SYAP1 by altering its synaptic associations. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Phalloidin stabilizes actin filaments, possibly causing abnormal synaptic organization. This could lead to an indirect inhibition of SYAP1 by disrupting normal synaptic function. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin is an inhibitor of myosin II. By affecting myosin II activity, and thereby influencing cytoskeletal dynamics, it can lead to an indirect inhibition of SYAP1 function within the synapse. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes actin filaments and can induce actin polymerization, potentially disrupting synaptic architecture and indirectly inhibiting SYAP1 by altering its synaptic localization and function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a dynamin inhibitor, a GTPase that is important for clathrin-mediated endocytosis. Inhibition of endocytosis could result in indirect inhibition of SYAP1 by affecting synaptic vesicle recycling. | ||||||
Neomycin sulfate | 1405-10-3 | sc-3573 sc-3573A | 1 g 5 g | $27.00 $35.00 | 20 | |
Neomycin disrupts phosphoinositide signaling by binding to phospholipids. Since SYAP1 is part of synaptic organization, phosphoinositide disruptions could lead to indirect inhibition of SYAP1's role in synapse structure. | ||||||